Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Nom du journal : Blood

Année : 2008

Volume : 111

Page de départ : 4022

Page de fin : 4028

Auteurs: Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, for the IRIS (International Randomized Interferon vs STI571) Study Group, Kantarjian HM,